Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review

References

• Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 2016;12(10):616–22. doi:10.1038/nrendo.2016.105. PMID:27388988.
   PubMed Web of Science ®Google Scholar
• Federation ID. IDF Diabetes Atlas, 7th edition: 2015. Brussels, Belgium [accessed 2017 April]. www.diabetesatlas.org.
   Google Scholar
• Bouter KP, Diepersloot RJ, van Romunde LK, Uitslager R, Masurel N, Hoekstra JB, Erkelens DW. Effect of epidemic influenza on ketoacidosis, pneumonia and death in diabetes mellitus: a hospital register survey of 1976–1979 in The Netherlands. Diabetes Res Clin Pract. 1991;12(1):61–68. doi:10.1016/0168-8227(91)90131-V. PMID:1906798.
   PubMed Web of Science ®Google Scholar
• Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, Fadel SA, Tran D, Fernandez E, Bhatnagar N, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347:f5061. doi:10.1136/bmj.f5061. doi:10.1136/bmj.f5061. PMID:23974637.
   PubMed Web of Science ®Google Scholar
• Valdez R, Narayan KM, Geiss LS, Engelgau MM. Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults. Am J Public Health. 1999;89(11):1715–21. doi:10.2105/AJPH.89.11.1715. PMID:10553394.
   PubMed Web of Science ®Google Scholar
• Grohskopf LA, Sokolow LZ, Broder KR, Olsen SJ, Karron RA, Jernigan DB, Bresee JS. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep. 2016;65(5):1–54. doi:10.15585/mmwr.rr6505a1. PMID:27560619.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Background paper on influenza vaccines and immunization: 2012 [accessed April 2017]. http://www.whoint/immunization/sage/meetings/2012/april/1_Background_Paper_Mar26_v13_cleaned.pdf.
   Google Scholar
• European Centre for Disease Prevention and Control. Priority risk groups for influenza vaccination: 2008 [accessed April 2017]. http://ecdc.europa.eu/en/publications/Publications/0808_GUI_Priority_Risk_Groups_for_Influenza_Vaccination.pdf.
   Google Scholar
• World Health Organization. Prevention and control of influenza pandemics and annual epidemics: 2003 [accessed April 2017]. http://www.who.int/immunization/sage/1_WHA56_19_Prevention_and_control_of_influenza_pandemics.pdf.
   Google Scholar
• Jimenez-Garcia R, Lopez-de-Andres A, Hernandez-Barrera V, Gómez-Campelo P, San Andrés-Rebollo FJ, de Burgos-Lunar C, Cárdenas-Valladolid J, Abánades-Herranz JC, Salinero-Fort MA. Influenza vaccination in people with type 2 diabetes, coverage, predictors of uptake, and perceptions. Result of the MADIABETES cohort a 7years follow up study. Vaccine. 2017;35(1):101–8. doi:10.1016/j.vaccine.2016.11.039. PMID:27890398.
   PubMed Web of Science ®Google Scholar
• Yang L, Nan H, Liang J, Chan YH, Chan L, Sum RW, Kwan YM, Zhou F, Meng H, Suen LK. Influenza vaccination in older people with diabetes and their household contacts. Vaccine. 2017;35(6):889–96. doi:10.1016/j.vaccine.2017.01.004. PMID:28094076.
   PubMed Web of Science ®Google Scholar
• Villarroel MA, Vahratian A. Vaccination coverage among adults with diagnosed diabetes: United States, 2015. NCHS Data Brief. 2016(265):1–8.
   Google Scholar
• Casanova L, Gobin N, Villani P, Verger P. Bias in the measure of the effectiveness of seasonal influenza vaccination among diabetics. Prim Care Diabetes. 2016;10(6):398–406. doi:10.1016/j.pcd.2016.05.005. PMID:27290610.
   PubMed Web of Science ®Google Scholar
• Remschmidt C, Wichmann O, Harder T. Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis. BMC Med. 2015;13:53. doi:10.1186/s12916-015-0295-6. PMID:25857236.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011) [accessed April 2017]. www.handbookcochrane.org.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9, w64. doi:10.7326/0003-4819-151-4-200908180-00135. PMID:19622511.
   PubMed Web of Science ®Google Scholar
• Scottish Intercollegiate Guidelines Network (SIGN). Critical appraisal: notes and checklists: 2015 [accessed April 2017]. http://www.sign.ac.uk/checklists-and-notes.html.
   Google Scholar
• Center for Biologics Evaluation and Research (CBER). Guidance for industry. Clinical data needed to support the licensure of seasonal inactivated influenza vaccines: 2007 [accessed April 2017]. https://www.fda.gov/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/vaccines/ucm074794.htm.
   Google Scholar
• Committee for Proprietary Medicinal Products (CPMP). Note for guidance on harmonisation of requirements for influenza vaccines: 1997 [accessed April 2017]. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003945.pdf.
   Google Scholar
• Weinberg GA, Szilagyi PG. Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap. J Infect Dis. 2010;201(11):1607–10. doi:10.1086/652404. PMID:20402594.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Questions and Answers. Vaccine effectiveness estimates for seasonal influenza vaccines: 2015 [accessed April 2017]. http://www.who.int/influenza/vaccines/virus/recommendations/201502_qanda_vaccineeffectiveness.pdf.
   Google Scholar
• Frasca D, Diaz A, Romero M, Mendez NV, Landin AM, Ryan JG, Blomberg BB. Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine. Vaccine. 2013;31(35):3603–10. doi:10.1016/j.vaccine.2013.05.003. PMID:23711934.
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Garneau H, Camous X, Dupuis G, Pawelec G, Baehl S, Tessier D, Frost EH, Frasca D, Larbi A, et al. Predictors of the antibody response to influenza vaccination in older adults with type 2 diabetes. BMJ Open Diabetes Res Care. 2015;3(1):e000140. doi:10.1136/bmjdrc-2015-000140. PMID:26504526.
   PubMed Web of Science ®Google Scholar
• Seo YB, Baek JH, Lee J, Song JY, Lee JS, Cheong HJ, Kim WJ. Long-term immunogenicity and safety of a conventional influenza vaccine in patients with type 2 diabetes. Clin Vaccine Immunol. 2015;22(11):1160–5. doi:10.1128/CVI.00288-15. PMID:26376926.
   PubMed Web of Science ®Google Scholar
• Sheridan PA, Paich HA, Handy J, Karlsson EA, Schultz-Cherry S, Hudgens M, Weir S, Noah T, Beck MA. The antibody response to influenza vaccination is not impaired in type 2 diabetics. Vaccine. 2015;33(29):3306–13. doi:10.1016/j.vaccine.2015.05.043. PMID:26044491.
   PubMed Web of Science ®Google Scholar
• Weinberg A, Boulware D, Dighero B, Orban T, Type 1 Diabetes TrialNet Abatacept Study Group. Effect of abatacept on immunogenicity of vaccines in individuals with type 1 diabetes. Vaccine. 2013;31(42):4791–4. doi:10.1016/j.vaccine.2013.07.086. PMID:23962535.
   PubMed Web of Science ®Google Scholar
• Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Vaccine. 2009;27(39):5357–62. doi:10.1016/j.vaccine.2009.06.082. PMID:19607951.
   PubMed Web of Science ®Google Scholar
• Hak E, Nordin J, Wei F, Mullooly J, Poblete S, Strikas R, Nichol KL. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis. 2002;35(4):370–7. doi:10.1086/341403. PMID:12145718.
   PubMed Web of Science ®Google Scholar
• Heffelfinger JD, Heckbert SR, Psaty BM, Weiss NS, Thompson WW, Bridges CB, Jackson LA. Influenza vaccination and risk of incident myocardial infarction. Hum Vaccin. 2006;2(4):161–6. doi:10.4161/hv.2.4.2943. PMID:17012887.
   PubMed Web of Science ®Google Scholar
• Heymann AD, Shapiro Y, Chodick G, Shalev V, Kokia E, Kramer E, Shemer J. Reduced hospitalizations and death associated with influenza vaccination among patients with and without diabetes. Diabetes Care. 2004;27(11):2581–4. doi:10.2337/diacare.27.11.2581. PMID:15504989.
   PubMed Web of Science ®Google Scholar
• Lau D, Eurich DT, Majumdar SR, Katz A, Johnson JA. Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study. Thorax. 2013;68(7):658–63. doi:10.1136/thoraxjnl-2012-203109. PMID:23535212.
   PubMed Web of Science ®Google Scholar
• Looijmans-Van den Akker I, Verheij TJ, Buskens E, Nichol KL, Rutten GE, Hak E. Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients. Diabetes Care. 2006;29(8):1771–6. doi:10.2337/dc05-2517. PMID:16873778.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Blanco T, Vila-Corcoles A, de Diego C, Ochoa-Gondar O, Valdivieso E, Bobe F, Morro A, Hernández N, Martin A, Calamote F, et al. Relationship between annual influenza vaccination and winter mortality in diabetic people over 65 years. Hum Vaccin Immunother. 2012;8(3):363–70. doi:10.4161/hv.18548. PMID:22327503.
   PubMed Web of Science ®Google Scholar
• Tacken MA, Braspenning JC, Berende A, Hak E, De Bakker DH, Groenewegen PP, Grol RP. Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data. Vaccine. 2004;22(23–24):2985–92. doi:10.1016/j.vaccine.2004.02.017..
   PubMed Web of Science ®Google Scholar
• Wang IK, Lin CL, Chang YC, Lin PC, Liang CC, Liu YL, Chang CT, Yen TH, Huang CC, Sung FC. Effectiveness of influenza vaccination in elderly diabetic patients: a retrospective cohort study. Vaccine. 2013;31(4):718–24. doi:10.1016/j.vaccine.2012.11.017. PMID:23153445.
   PubMed Web of Science ®Google Scholar
• Vamos EP, Pape UJ, Curcin V, Harris MJ, Valabhji J, Majeed A, Millett C. Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes. CMAJ. 2016;188(14):E342–51. doi:10.1503/cmaj.151059. PMID:27455981.
   PubMed Web of Science ®Google Scholar
• Demicheli V, Jefferson T, Al-Ansary LA, Ferroni E, Rivetti A, Di Pietrantonj C. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2014;(3):CD001269. doi:10.1002/14651858.CD001269.pub5. PMID:24623315.
   PubMed Web of Science ®Google Scholar
• Haq K, Fulop T, Tedder G, Gentleman B, Garneau H, Meneilly GS, Kleppinger A, Pawelec G, McElhaney JE. Cytomegalovirus Seropositivity predicts a decline in the T cell but not the antibody response to influenza in vaccinated older adults independent of type 2 diabetes status. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences. 2016; glw216. doi:10.1093/gerona/glw216..
   Web of Science ®Google Scholar
• Dos Santos G, Neumeier E, Bekkat-Berkani R. Influenza: Can we cope better with the unpredictable? Hum Vaccin Immunother. 2016;12(3):699–708. doi:10.1080/21645515.2015.1086047. PMID:26360135.
   PubMed Web of Science ®Google Scholar
• Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006;35(2):337–44. doi:10.1093/ije/dyi274. PMID:16368725.
   PubMed Web of Science ®Google Scholar